APO Research
Talk to an analyst

APO RESEARCH · REPORT

Genomics Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Genomics Software Market Outlook and Growth Opportunities 2026

22 December 2025199 pages

Choose your research edition.

Industry ResearchGenomics Software Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Genomics Software Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Genomics Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genomics Software Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Genomics Software Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Genomics Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Genomics Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Genomics Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Genomics Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Genomics Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Genomics Software market include Agilent Technologies, SAS (JMP Genomics), Thermo Fisher Scientific, QIAGEN Digital Insights, DNASTAR, Inc, Fabric Genomics and Biomatters (Geneious), among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Genomics Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Genomics Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Genomics Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Genomics Software market.

Genomics Software Segment by Company

Agilent Technologies

SAS (JMP Genomics)

Thermo Fisher Scientific

QIAGEN Digital Insights

DNASTAR, Inc

Fabric Genomics

Biomatters (Geneious)

Genomics Software Segment by Type

On-Premise

Cloud Based

Genomics Software Segment by Application

Hospitals and Health Systems

Research Organizations

Others

Genomics Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Genomics Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Genomics Software key companies, revenue, market share, and recent developments.

3. To split the Genomics Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Genomics Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Genomics Software significant trends, drivers, influence factors in global and regions.

6. To analyze Genomics Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genomics Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genomics Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genomics Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Genomics Software industry.

Chapter 3: Detailed analysis of Genomics Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Genomics Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Genomics Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Genomics Software Industry Trends Table 2. Genomics Software Industry Drivers Table 3. Genomics Software Industry Opportunities and Challenges Table 4. Genomics Software Industry Restraints Table 5. Global Genomics Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Genomics Software Revenue Share by Company (2021-2026) Table 7. Global Genomics Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Genomics Software Key Company Manufacturing Base & Headquarters Table 9. Global Genomics Software Company, Product Type & Application Table 10. Global Genomics Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Genomics Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of On-Premise Table 15. Significant Companies of Cloud Based Table 16. Global Genomics Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Genomics Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Genomics Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Genomics Software Sales Value Share by Type (2021-2026) Table 20. Global Genomics Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospitals and Health Systems Table 22. Significant Companies of Research Organizations Table 23. Significant Companies of Others Table 24. Global Genomics Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Genomics Software Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Genomics Software Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Genomics Software Sales Value Share by Application (2021-2026) Table 28. Global Genomics Software Sales Value Share by Application (2027-2032) Table 29. Global Genomics Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Genomics Software Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Genomics Software Sales Value Share by Region (2021-2026) Table 32. Global Genomics Software Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Genomics Software Sales Value Share by Region (2027-2032) Table 34. Global Genomics Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Genomics Software Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Genomics Software Sales Value Market Share by Country (2021-2026) Table 37. Global Genomics Software Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Genomics Software Sales Value Market Share by Country (2027-2032) Table 39. Agilent Technologies Company Information Table 40. Agilent Technologies Business Overview Table 41. Agilent Technologies Genomics Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Agilent Technologies Genomics Software Product Portfolio Table 43. Agilent Technologies Recent Development Table 44. SAS (JMP Genomics) Company Information Table 45. SAS (JMP Genomics) Business Overview Table 46. SAS (JMP Genomics) Genomics Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. SAS (JMP Genomics) Genomics Software Product Portfolio Table 48. SAS (JMP Genomics) Recent Development Table 49. Thermo Fisher Scientific Company Information Table 50. Thermo Fisher Scientific Business Overview Table 51. Thermo Fisher Scientific Genomics Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Thermo Fisher Scientific Genomics Software Product Portfolio Table 53. Thermo Fisher Scientific Recent Development Table 54. QIAGEN Digital Insights Company Information Table 55. QIAGEN Digital Insights Business Overview Table 56. QIAGEN Digital Insights Genomics Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. QIAGEN Digital Insights Genomics Software Product Portfolio Table 58. QIAGEN Digital Insights Recent Development Table 59. DNASTAR, Inc Company Information Table 60. DNASTAR, Inc Business Overview Table 61. DNASTAR, Inc Genomics Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. DNASTAR, Inc Genomics Software Product Portfolio Table 63. DNASTAR, Inc Recent Development Table 64. Fabric Genomics Company Information Table 65. Fabric Genomics Business Overview Table 66. Fabric Genomics Genomics Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Fabric Genomics Genomics Software Product Portfolio Table 68. Fabric Genomics Recent Development Table 69. Biomatters (Geneious) Company Information Table 70. Biomatters (Geneious) Business Overview Table 71. Biomatters (Geneious) Genomics Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Biomatters (Geneious) Genomics Software Product Portfolio Table 73. Biomatters (Geneious) Recent Development Table 74. Research Programs/Design for This Report Table 75. Authors List of This Report Table 76. Secondary Sources Table 77. Primary Sources List of Figures Figure 1. Genomics Software Product Image Figure 2. Global Genomics Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Genomics Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Genomics Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. On-Premise Image Figure 8. Cloud Based Image Figure 9. Global Genomics Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Genomics Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Genomics Software Sales Value Share by Type (2021-2032) Figure 12. Hospitals and Health Systems Image Figure 13. Research Organizations Image Figure 14. Others Image Figure 15. Global Genomics Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Genomics Software Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Genomics Software Sales Value Share by Application (2021-2032) Figure 18. Global Genomics Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Genomics Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Genomics Software Sales Value (2021-2032) & (US$ Million) Figure 21. North America Genomics Software Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Genomics Software Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Genomics Software Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Genomics Software Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Genomics Software Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Genomics Software Sales Value (2021-2032) & (US$ Million) Figure 27. South America Genomics Software Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Genomics Software Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Genomics Software Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Genomics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Genomics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Genomics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • On-Premise
  • Cloud Based
Applications
  • Hospitals and Health Systems
  • Research Organizations
  • Others
Companies covered
  • Agilent Technologies
  • SAS (JMP Genomics)
  • Thermo Fisher Scientific
  • QIAGEN Digital Insights
  • DNASTAR, Inc
  • Fabric Genomics
  • Biomatters (Geneious)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Genomics Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Genomics Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Genomics Software Market Dynamics
  1. 2.1 Genomics Software Industry Trends
  2. 2.2 Genomics Software Industry Drivers
  3. 2.3 Genomics Software Industry Opportunities and Challenges
  4. 2.4 Genomics Software Industry Restraints
3 Genomics Software Market by Company
  1. 3.1 Global Genomics Software Company Revenue Ranking in 2025
  2. 3.2 Global Genomics Software Revenue by Company (2021-2026)
  3. 3.3 Global Genomics Software Company Ranking (2024-2026)
  4. 3.4 Global Genomics Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Genomics Software Company Product Type and Application
  6. 3.6 Global Genomics Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Genomics Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Genomics Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Genomics Software Market by Type
  1. 4.1 Genomics Software Type Introduction
  2. 4.1.1 On-Premise
  3. 4.1.2 Cloud Based
  4. 4.2 Global Genomics Software Sales Value by Type
  5. 4.2.1 Global Genomics Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Genomics Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global Genomics Software Sales Value Share by Type (2021-2032)
5 Genomics Software Market by Application
  1. 5.1 Genomics Software Application Introduction
  2. 5.1.1 Hospitals and Health Systems
  3. 5.1.2 Research Organizations
  4. 5.1.3 Others
  5. 5.2 Global Genomics Software Sales Value by Application
  6. 5.2.1 Global Genomics Software Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Genomics Software Sales Value by Application (2021-2032)
  8. 5.2.3 Global Genomics Software Sales Value Share by Application (2021-2032)
6 Genomics Software Regional Value Analysis
  1. 6.1 Global Genomics Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Genomics Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Genomics Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Genomics Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Genomics Software Sales Value (2021-2032)
  7. 6.3.2 North America Genomics Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Genomics Software Sales Value (2021-2032)
  10. 6.4.2 Europe Genomics Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Genomics Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Genomics Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Genomics Software Sales Value (2021-2032)
  16. 6.6.2 South America Genomics Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Genomics Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Genomics Software Sales Value Share by Country, 2025 VS 2032
7 Genomics Software Country-level Value Analysis
  1. 7.1 Global Genomics Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Genomics Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Genomics Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Genomics Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Genomics Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Genomics Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Genomics Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Genomics Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Genomics Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Genomics Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Genomics Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Genomics Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Genomics Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Genomics Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Genomics Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Genomics Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Genomics Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Genomics Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Genomics Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Genomics Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Genomics Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Genomics Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Genomics Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Genomics Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Genomics Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Genomics Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Genomics Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Genomics Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Genomics Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Genomics Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Genomics Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Genomics Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Genomics Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Genomics Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Genomics Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Genomics Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Genomics Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Genomics Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Genomics Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Genomics Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Genomics Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Genomics Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Genomics Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Genomics Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Genomics Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Genomics Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Genomics Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Genomics Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Genomics Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Genomics Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Genomics Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Genomics Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Genomics Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Genomics Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Genomics Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Genomics Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Genomics Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Genomics Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Genomics Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Genomics Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Genomics Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Genomics Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Genomics Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Genomics Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Genomics Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Genomics Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Genomics Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Genomics Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Genomics Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Genomics Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Genomics Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Genomics Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Genomics Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Genomics Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Genomics Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Genomics Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Genomics Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Genomics Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Genomics Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Genomics Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Genomics Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Genomics Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Genomics Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Genomics Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Genomics Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Genomics Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Genomics Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Genomics Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Agilent Technologies
  2. 8.1.1 Agilent Technologies Company Information
  3. 8.1.2 Agilent Technologies Business Overview
  4. 8.1.3 Agilent Technologies Genomics Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Agilent Technologies Genomics Software Product Portfolio
  6. 8.1.5 Agilent Technologies Recent Developments
  7. 8.2 SAS (JMP Genomics)
  8. 8.2.1 SAS (JMP Genomics) Company Information
  9. 8.2.2 SAS (JMP Genomics) Business Overview
  10. 8.2.3 SAS (JMP Genomics) Genomics Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 SAS (JMP Genomics) Genomics Software Product Portfolio
  12. 8.2.5 SAS (JMP Genomics) Recent Developments
  13. 8.3 Thermo Fisher Scientific
  14. 8.3.1 Thermo Fisher Scientific Company Information
  15. 8.3.2 Thermo Fisher Scientific Business Overview
  16. 8.3.3 Thermo Fisher Scientific Genomics Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Thermo Fisher Scientific Genomics Software Product Portfolio
  18. 8.3.5 Thermo Fisher Scientific Recent Developments
  19. 8.4 QIAGEN Digital Insights
  20. 8.4.1 QIAGEN Digital Insights Company Information
  21. 8.4.2 QIAGEN Digital Insights Business Overview
  22. 8.4.3 QIAGEN Digital Insights Genomics Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 QIAGEN Digital Insights Genomics Software Product Portfolio
  24. 8.4.5 QIAGEN Digital Insights Recent Developments
  25. 8.5 DNASTAR, Inc
  26. 8.5.1 DNASTAR, Inc Company Information
  27. 8.5.2 DNASTAR, Inc Business Overview
  28. 8.5.3 DNASTAR, Inc Genomics Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 DNASTAR, Inc Genomics Software Product Portfolio
  30. 8.5.5 DNASTAR, Inc Recent Developments
  31. 8.6 Fabric Genomics
  32. 8.6.1 Fabric Genomics Company Information
  33. 8.6.2 Fabric Genomics Business Overview
  34. 8.6.3 Fabric Genomics Genomics Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Fabric Genomics Genomics Software Product Portfolio
  36. 8.6.5 Fabric Genomics Recent Developments
  37. 8.7 Biomatters (Geneious)
  38. 8.7.1 Biomatters (Geneious) Company Information
  39. 8.7.2 Biomatters (Geneious) Business Overview
  40. 8.7.3 Biomatters (Geneious) Genomics Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Biomatters (Geneious) Genomics Software Product Portfolio
  42. 8.7.5 Biomatters (Geneious) Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst